Literature DB >> 6967053

Clonal extinction of myelomonocytic leukemic cells by serum from mice injected with endotoxin.

D Metcalf.   

Abstract

Culture of WEHI-3B myelomonocytic leukemic cells in semi-solid agar medium containing post-endotoxin serum led to the development of maturing granulocytes and macrophages in most leukemic colonies. Colony size was consistently increased but the colony content of colony-forming cells (stem-cell self-replication) was markedly reduced. Serial recloning of WEHI-3B colony cells in the continuous presence of post-endotoxin serum led to clonal extinction of the leukemic cells in five of seven experiments. These effects of post-endotoxin serum on WEHI-3B cells were not seen in clonal cultures of 10 other tumor lines. Serum with the capacity to induce differentiation in WEHI-3B cells could be induced by the injection of as little as 0.1 microgram endotoxin and by purified bacterial cell-wall preparations. Serum activity reached peak levels 3 - 6 h after endotoxin injection and returned to preinjection levels within 48 h.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6967053     DOI: 10.1002/ijc.2910250210

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Localization of the human G-CSF gene to the region of a breakpoint in the translocation typical of acute promyelocytic leukemia.

Authors:  R N Simmers; J Smith; M F Shannon; G Wong; A F Lopez; E Baker; G R Sutherland; M A Vadas
Journal:  Hum Genet       Date:  1988-02       Impact factor: 4.132

2.  Colony stimulating factor-induced differentiation of murine M1 myeloid leukemia cells is permissive in early G1 phase.

Authors:  H Tsuda; L M Neckers; D H Pluznik
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

Review 3.  Human granulocyte colony stimulating factor.

Authors:  E Platzer; J R Kalden
Journal:  Blut       Date:  1987-03

Review 4.  Is there a role for differentiating therapy in non-APL AML?

Authors:  H Phillip Koeffler
Journal:  Best Pract Res Clin Haematol       Date:  2010-11-23       Impact factor: 3.020

5.  Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor.

Authors:  K Welte; E Platzer; L Lu; J L Gabrilove; E Levi; R Mertelsmann; M A Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

6.  Granulocyte/macrophage colony-stimulating factor from mouse lung conditioned medium. Purification of multiple forms and radioiodination.

Authors:  A W Burgess; D Metcalf; L G Sparrow; R J Simpson; E C Nice
Journal:  Biochem J       Date:  1986-05-01       Impact factor: 3.857

7.  Pluripoietin alpha: a second human hematopoietic colony-stimulating factor produced by the human bladder carcinoma cell line 5637.

Authors:  J L Gabrilove; K Welte; P Harris; E Platzer; L Lu; E Levi; R Mertelsmann; M A Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

8.  T-cell receptor and immunoglobulin genes are rearranged together in Abelson virus-transformed pre-B and pre-T cells.

Authors:  W D Cook; A M Balaton
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

9.  Differential expression of c-fos in hematopoietic cells: correlation with differentiation of monomyelocytic cells in vitro.

Authors:  R Müller; D Müller; L Guilbert
Journal:  EMBO J       Date:  1984-08       Impact factor: 11.598

10.  Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells.

Authors:  E Platzer; K Welte; J L Gabrilove; L Lu; P Harris; R Mertelsmann; M A Moore
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.